AbbVie (ABBV)
(Delayed Data from NYSE)
$173.61 USD
+1.29 (0.75%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $173.95 +0.34 (0.20%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth F Momentum D VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO7/25/24 |
---|---|
Current Quarter | 2.56 |
EPS Last Quarter | 2.31 |
Last EPS Surprise | 2.21% |
ABR | 1.67 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 10.81 |
Next Year | 12.13 |
EPS (TTM) | 10.96 |
P/E (F1) | 16.06 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 14.05B | 14.15B | 55.35B | 58.86B |
# of Estimates | 9 | 9 | 9 | 9 |
High Estimate | 14.22B | 14.42B | 56.03B | 60.19B |
Low Estimate | 13.91B | 13.94B | 54.79B | 57.18B |
Year ago Sales | 13.87B | 13.93B | 54.32B | 55.35B |
Year over Year Growth Est. | 1.30% | 1.63% | 1.89% | 6.35% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.56 | 2.90 | 10.81 | 12.13 |
# of Estimates | 7 | 9 | 9 | 11 |
Most Recent Consensus | 2.56 | 2.87 | 10.79 | 11.99 |
High Estimate | 2.59 | 2.97 | 11.25 | 12.71 |
Low Estimate | 2.54 | 2.84 | 10.61 | 11.74 |
Year ago EPS | 2.91 | 2.95 | 11.11 | 10.81 |
Year over Year Growth Est. | -12.03% | -1.69% | -2.70% | 12.22% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 1 |
Up Last 30 Days | 0 | 1 | 0 | 2 |
Up Last 60 Days | 0 | 2 | 0 | 3 |
Down Last 7 Days | 3 | 1 | 3 | 1 |
Down Last 30 Days | 7 | 3 | 8 | 3 |
Down Last 60 Days | 7 | 3 | 8 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 2.56 | 2.90 | 10.81 | 12.13 |
7 Days Ago | 2.78 | 2.90 | 10.99 | 12.12 |
30 Days Ago | 3.07 | 2.89 | 11.27 | 12.10 |
60 Days Ago | 3.07 | 2.88 | 11.27 | 12.08 |
90 Days Ago | 2.77 | 2.91 | 11.11 | 12.13 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 2.56 | 2.90 | 10.76 | 12.18 |
Zacks Consensus Estimate | 2.56 | 2.90 | 10.81 | 12.13 |
Earnings ESP | 0.00% | 0.04% | -0.50% | 0.36% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 2.31 | 2.79 | 2.95 | 2.91 | NA |
Estimate | 2.26 | 2.76 | 2.86 | 2.79 | NA |
Difference | 0.05 | 0.03 | 0.09 | 0.12 | 0.07 |
Surprise | 2.21% | 1.09% | 3.15% | 4.30% | 2.69% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more